4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression (Homo sapiens)
From WikiPathways
Description
This pathway is modeled after Figure 7 in the article Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids (See Bibliography). Several anticancer agents up-regulate expression of p27, a cyclin-dpendent kinase inhibitor that blocks the transition from G1 to S phase. The pathways used by the anticancer agents (retinoic acids, 4-hydroxytamoxifen, dexamethasone) are shown above from human breast cancer cells.
Quality Tags
Ontology Terms
Bibliography
- Eto I; ''Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids.''; Cancer Cell Int, 2010 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
| View all... |
| Name | Type | Database reference | Comment |
|---|---|---|---|
| 4-Hydroxytamoxifen | Metabolite | 449459 (PubChem-compound) ![]() | |
| AICA riboside compound C | Metabolite | 17513 (PubChem-compound) ![]() | |
| AKT | GeneProduct | ENSG00000142208 (Ensembl) ![]() | |
| AMPK | GeneProduct | Q13131 (Uniprot-TrEMBL) ![]() | |
| Cancer | Q12078 (Wikidata) ![]() | ||
| Cap-independent translation initiation of p27 mRNA through its 5'UTR | Pathway | Identifier not found | |
| Dexamethasone | Metabolite | 5743 (PubChem-compound) ![]() | |
| EIF4EBP1 | GeneProduct | ENSG00000187840 (Ensembl) ![]() | |
| ERK inhibitor I | Metabolite | 3377241 (PubChem-compound) ![]() | |
| ERK1 | GeneProduct | ENSG00000102882 (Ensembl) ![]() | |
| ERK2 | GeneProduct | ENSG00000100030 (Ensembl) ![]() | |
| LY 294, 002 | Metabolite | 3973 (PubChem-compound) ![]() | |
| MEK1 | GeneProduct | ENSG00000169032 (Ensembl) ![]() | |
| MEK2 | GeneProduct | ENSG00000126934 (Ensembl) ![]() | |
| MKK3 | GeneProduct | ENSG00000034152 (Ensembl) ![]() | |
| MKK6 | GeneProduct | ENSG00000108984 (Ensembl) ![]() | |
| MNK1 | GeneProduct | ENSG00000079277 (Ensembl) ![]() | |
| MNK2 | GeneProduct | ENSG00000099875 (Ensembl) ![]() | |
| Mlk3 | GeneProduct | ENSG00000173327 (Ensembl) ![]() | |
| NSC119889 | Metabolite | 274104 (PubChem-compound) ![]() | |
| PBK | GeneProduct | ENSG00000168078 (Ensembl) ![]() | |
| PD98059 | Metabolite | 4713 (PubChem-compound) ![]() | |
| PIK3CA | GeneProduct | PIK3CA (HGNC) ![]() | |
| PIK3CB | GeneProduct | PIK3CB (HGNC) ![]() | |
| PIK3CD | GeneProduct | PIK3CD (HGNC) ![]() | |
| PIK3R1 | GeneProduct | PIK3R1 (HGNC) ![]() | |
| PIK3R2 | GeneProduct | PIK3R2 (HGNC) ![]() | |
| PIK3R3 | GeneProduct | PIK3R3 (HGNC) ![]() | |
| Raf | GeneProduct | ENSG00000132155 (Ensembl) ![]() | |
| Retinoic acids? | Metabolite | HMDB0001852 (HMDB) ![]() | |
| Rotenone | Metabolite | 6758 (PubChem-compound) ![]() | |
| SB202190 | Metabolite | 5353940 (PubChem-compound) ![]() | |
| TSC1 | GeneProduct | TSC1 (HGNC) ![]() | |
| TSC2 | GeneProduct | TSC2 (HGNC) ![]() | |
| Triciribine | Metabolite | 65399 (PubChem-compound) ![]() | |
| eIF4E | GeneProduct | ENSG00000151247 (Ensembl) ![]() | |
| mTOR | GeneProduct | ENSG00000198793 (Ensembl) ![]() | |
| p38MAPK | GeneProduct | ENSG00000197442 (Ensembl) ![]() |
Annotated Interactions
No annotated interactions
Saving...

